To print this article, simply register or log in to Mondaq.com.
This month’s capital snapshot
- Take a look at the July policy and politics timeline, and the remaining 2022 parliamentary calendar.
- An overview of top priority policies and legislative priorities in the coming months.
- The impact of three groundbreaking Supreme Court proceedings on American politics and public policy during the election year.
July 2022 Parliamentary Schedule and Priorities
Number of days remaining in parliament
Possible adjustment package updates
- Recently, Senator Joe Manchin (D-WV) said he would accept a “more skinny” settlement bill that focused on:
- Inflation and deficit reduction, including certain tax reforms. Senator Manchin especially wants to raise corporate taxes.
- Price reform of prescription drugs.
- Climate and energy consumption.
- In recent weeks, Senator Manchin and majority leader Chuck Schumer (D-NY) have met many times to discuss the possibility of a reconciliation bill. These meetings were frequent in late June, with four meetings a week on June 20th.
- Senate Democrats may submit legislative texts on drug price reforms to Senators that can be included in the settlement bill. (Members are responsible for determining whether the language complies with the Senate’s budget adjustment rules.)
- If an agreement is reached, the team of leader shooters is targeting early July or early August for potential voting on such packages.
- All transactions that the Senate Democratic Party may make with Senator Manchin must be approved by Senator Kyrsten Sinema (D-AZ). We believe there is still a significant gap between what Senator Manchin and Senator Cinema want in the deal, including various tax policies.
Majority leader Chuck Schumer (D-NY)
Senator Joe Manchin (D-WV)
* Dilpreet Kaur and Jirayu (Chow) Pauleksakon contributed to this advisory.
Click here to read the full article
The content of this article is intended to provide a general guide to the subject. Expert advice should be sought for certain situations.
Popular Articles: US Food, Pharmaceuticals, Healthcare, Life Sciences
..
